PAMELA JEAN ST CLAIR
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PORTLAND, OR NPI 1346859907
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OR Acerta Pharma LLC All categories
General Payments — all program years on this page
$754.03
- Category: General Payments
- Program years: PY2023–2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $508.44 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $409.43 | 5 |
| Education | $99.01 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $277.31 | 3 |
| Daiichi Sankyo Inc. | $121.36 | 1 |
| Genmab U.S., Inc. | $92.63 | 1 |
| Legend Biotech USA Inc. | $17.14 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089486250 | Daiichi Sankyo Inc. | $121.36 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104313486 | AstraZeneca Pharmaceuticals LP | $97.52 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104461178 | AstraZeneca Pharmaceuticals LP | $99.01 | 11/20/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1105809371 | AstraZeneca Pharmaceuticals LP | $80.78 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126838586 | Genmab U.S., Inc. | $92.63 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131692232 | Legend Biotech USA Inc. | $17.14 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.